Sterling Pharmaceutical Services LLC – FDA 483, May 1, 2024
This FDA Form 483 details significant deficiencies at Sterling Pharmaceutical Services LLC, a sterile ophthalmic manufacturer in Dupo, IL. The firm repeatedly failed to thoroughly investigate microbial contamination, including Bacillus cereus, and released commercial lots without definitive root cause analysis or adequate aseptic process simulations. Other critical issues include inadequate environmental monitoring, cleaning/disinfection validation, equipment maintenance, and control procedures for water systems and analytical methods, indicating a systemic lack of control over sterile manufacturing processes.
ID · 3bd2df63-7eb4-41b8-bea0-7f8ba72de3a7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.